Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-15 Sale | 2024-04-17 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 19,582 | $59.91 | $1,173,232 | 408,122 (Indirect Direct) | View |
| 2024-03-15 Sale | 2024-03-18 5:45 pm | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 3,524 | $72.69 | $256,160 | 36,476 (Direct) | View |
| 2024-03-15 Sale | 2024-03-18 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $72.48 | $1,449,628 | 427,704 (Indirect Direct) | View |
| 2024-03-11 Sale | 2024-03-12 5:45 pm | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 3,947 | $77.15 | $304,515 | 79,924 (Direct) | View |
| 2024-03-11 Sale | 2024-03-12 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 14,385 | $77.04 | $1,108,263 | 474,872 (Indirect Direct) | View |
| 2024-02-20 Sale | 2024-02-21 5:45 pm | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 1,913 | $79.67 | $152,409 | 65,021 (Direct) | View |
| 2024-02-20 Sale | 2024-02-21 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 6,370 | $79.67 | $507,498 | 420,757 (Indirect Direct) | View |
| 2024-02-15 Sale | 2024-02-16 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $80.36 | $1,607,177 | 426,959 (Indirect Direct) | View |
| 2024-01-29 Sale | 2024-01-31 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 50,000 | $60.51 | $3,025,573 | 487,377 (Indirect Direct) | View |
| 2024-01-16 Sale | 2024-01-18 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $62.5 | $1,250,058 | 446,959 (Indirect Direct) | View |
| 2023-05-30 Sale | 2023-06-01 5:44 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $64.88 | $1,621,894 | 466,959 (Direct) | View |
| 2023-04-25 Sale | 2023-04-27 5:37 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $50.67 | $1,266,638 | 491,959 (Direct) | View |
| 2023-03-29 Sale | 2023-03-31 5:49 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $44.46 | $1,111,504 | 516,959 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 6:11 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $48.25 | $1,206,243 | 530,570 (Direct) | View |
| 2023-01-27 Sale | 2023-01-31 5:34 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $51.47 | $1,286,798 | 548,693 (Direct) | View |
| 2022-12-28 Sale | 2022-12-30 5:33 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $40.93 | $1,023,290 | 573,693 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-15 Exercise | 2024-04-17 5:45 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 19,582 | $0 | 408,122 (Direct) | View |
| 2024-04-15 Exercise | 2024-04-17 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 19,582 | $19.12 | 408,122 (Direct) | View |
| 2024-03-20 Option Award | 2024-03-22 5:45 pm | N/A 2034-03-20 | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 58,333 | $0 | 58,333 (Direct) | View |
| 2024-03-20 Option Award | 2024-03-22 5:45 pm | N/A 2034-03-20 | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 61,168 | $0 | 61,168 (Direct) | View |
| 2024-03-20 Option Award | 2024-03-22 5:45 pm | N/A 2034-03-20 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 183,750 | $0 | 183,750 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-18 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 10,000 | $0 | 36,476 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-18 5:45 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $0 | 427,704 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-18 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $19.12 | 427,704 (Direct) | View |
| 2024-03-10 Exercise | 2024-03-12 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 7,750 | $0 | 79,924 (Direct) | View |
| 2024-03-10 Exercise | 2024-03-12 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 28,250 | $0 | 474,872 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-27 6:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | George Simeon Director | 1,048,951 | $71.5 | 769,196 (Indirect) | View |
| 2024-02-18 Exercise | 2024-02-21 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 3,825 | $0 | 65,021 (Direct) | View |
| 2024-02-18 Exercise | 2024-02-21 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 13,250 | $0 | 420,757 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-16 5:45 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $0 | 426,959 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-16 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $19.12 | 426,959 (Direct) | View |
| 2024-01-29 Exercise | 2024-01-31 5:45 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 50,000 | $0 | 487,377 (Direct) | View |
| 2024-01-29 Exercise | 2024-01-31 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 50,000 | $19.12 | 487,377 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 5:45 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $0 | 446,959 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $19.12 | 446,959 (Direct) | View |
| 2023-10-13 Option Award | 2023-10-17 5:52 pm | N/A 2033-10-13 | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 13,832 | $0 | 13,832 (Direct) | View |
| 2023-10-13 Option Award | 2023-10-17 5:52 pm | N/A 2033-10-13 | CRISPR Therapeutics AG | CRSP | Morrow Phuong Khanh Chief Medical Officer | 16,667 | $0 | 16,667 (Direct) | View |
| 2023-10-13 Option Award | 2023-10-17 5:51 pm | N/A 2033-10-13 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 77,500 | $0 | 77,500 (Direct) | View |
| 2023-10-13 Option Award | 2023-10-17 5:48 pm | N/A 2033-10-13 | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 23,007 | $0 | 23,007 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 5:56 pm | N/A 2033-06-08 | CRISPR Therapeutics AG | CRSP | George Simeon Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 5:48 pm | N/A 2033-06-08 | CRISPR Therapeutics AG | CRSP | Behbahani Ali Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 5:36 pm | N/A 2033-06-08 | CRISPR Therapeutics AG | CRSP | Treco Douglas A Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 5:36 pm | N/A 2033-06-08 | CRISPR Therapeutics AG | CRSP | High Katherine A Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 5:34 pm | N/A 2033-06-08 | CRISPR Therapeutics AG | CRSP | Greene John Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 5:34 pm | N/A 2033-06-08 | CRISPR Therapeutics AG | CRSP | Fleming Harold Edward Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 5:33 pm | N/A 2033-06-08 | CRISPR Therapeutics AG | CRSP | Fardis Maria Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2023-05-30 Exercise | 2023-06-01 5:44 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 466,959 (Direct) | View |
| 2023-05-30 Exercise | 2023-06-01 5:44 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $19.12 | 466,959 (Direct) | View |
| 2023-05-24 Tax Withholding | 2023-05-25 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Morrow Phuong Khanh Chief Medical Officer | 2,527 | $65.91 | 25,223 (Direct) | View |
| 2023-05-23 Exercise | 2023-05-25 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Morrow Phuong Khanh Chief Medical Officer | 6,938 | $0 | 25,223 (Direct) | View |
| 2023-04-25 Exercise | 2023-04-27 5:37 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 491,959 (Direct) | View |
| 2023-04-25 Exercise | 2023-04-27 5:37 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $19.12 | 491,959 (Direct) | View |
| 2023-03-29 Exercise | 2023-03-31 5:49 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 516,959 (Direct) | View |
| 2023-03-29 Exercise | 2023-03-31 5:49 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $19.12 | 516,959 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-14 5:50 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 140,000 | $0 | 140,000 (Direct) | View |
| 2023-03-13 Tax Withholding | 2023-03-14 5:47 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 9,444 | $43.22 | 670,377 (Direct) | View |
| 2023-03-10 Exercise | 2023-03-14 5:47 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,833 | $0 | 670,377 (Direct) | View |
| 2023-03-10 Option Award | 2023-03-14 5:47 pm | N/A 2033-03-10 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 265,000 | $0 | 670,377 (Direct) | View |
| 2023-03-13 Tax Withholding | 2023-03-14 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 2,305 | $43.22 | 121,344 (Direct) | View |
| 2023-03-10 Exercise | 2023-03-14 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 5,083 | $0 | 121,344 (Direct) | View |
| 2023-03-10 Option Award | 2023-03-14 5:45 pm | N/A 2033-03-10 | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 62,000 | $0 | 121,344 (Direct) | View |
| 2023-03-10 Option Award | 2023-03-14 5:44 pm | N/A 2033-03-10 | CRISPR Therapeutics AG | CRSP | Morrow Phuong Khanh Chief Medical Officer | 66,620 | $0 | 66,620 (Direct) | View |
| 2023-02-27 Exercise | 2023-03-01 6:11 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 530,570 (Direct) | View |
| 2023-02-27 Exercise | 2023-03-01 6:11 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $19.12 | 530,570 (Direct) | View |
| 2023-02-21 Tax Withholding | 2023-02-22 5:41 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer | 1,392 | $48.26 | 16,547 (Direct) | View |
| 2023-02-18 Exercise | 2023-02-22 5:41 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer | 3,825 | $0 | 16,547 (Direct) | View |
| 2023-02-21 Tax Withholding | 2023-02-22 5:38 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 6,373 | $48.26 | 415,738 (Direct) | View |
| 2023-02-18 Exercise | 2023-02-22 5:38 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 13,250 | $0 | 415,738 (Direct) | View |
| 2023-02-21 Tax Withholding | 2023-02-22 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 1,950 | $48.26 | 63,541 (Direct) | View |
| 2023-02-18 Exercise | 2023-02-22 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 3,825 | $0 | 63,541 (Direct) | View |
| 2023-01-27 Exercise | 2023-01-31 5:34 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 548,693 (Direct) | View |
| 2023-01-27 Exercise | 2023-01-31 5:34 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $19.12 | 548,693 (Direct) | View |
| 2022-12-28 Exercise | 2022-12-30 5:33 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 573,693 (Direct) | View |
| 2022-12-28 Exercise | 2022-12-30 5:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $19.12 | 573,693 (Direct) | View |